WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-01·Latest →

Intuitive Surgical (ISRG) Stock Analysis

OW

ISRG Equity Research — OVERWEIGHT — July 2026

← GILDJNJ →

Rating date

Jul 1, 2026

40 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

42p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · ISRG

Here is the analysis note on ISRG (Intuitive Surgical).

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Low

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • Bearish trend intact: ISRG has been in a persistent downtrend for 12 months, with no clear reversal pattern on the daily chart.
  • RSI improving but not confirming a reversal: While RSI has lifted out of oversold territory (31.9 → 41.6), it remains below 50, indicating sellers still have the edge.
  • Critical support at ~$393 (Bollinger lower band): A close below this level would open the door to further downside. A reclaim of the $410 middle band would be the first sign of stabilization.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

ISRG Research Note

Full desk note for Jul 1, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

29 min read

WebserviceX · Agentic Research Desk

ISRG Equity Research Note

Published Jul 1, 2026 · Desk view OVERWEIGHT · Generated 2026-07-02T20:31:40Z · Maintained by Walter Vijayakumar · Methodology · Track record

ISRG Stock Rating Summary

ISRG bias

OVERWEIGHT

Horizon

Short to medium term

ISRG key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

ISRG catalyst watch

Bearish trend intact: ISRG has been in a persistent downtrend for 12 months, with no clear reversal pattern on the daily chart.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Low

How the call aged · 5D

—Awaiting market dataPeer 42p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-02T20:45:22.166962+00:00.

5D move

—

2026-07-01 → awaiting

Outcome

Awaiting market data

5D trend

+0.14%

Vol (20D ann.)

+25.30%

vs SPY: -1.57%

Close 402.38 → — (USD, vendor closes)

Batch scorecard · 2026-07-01 · ISRG

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace f4310191…

No QC issues recorded.